  | Koopmansch, B., Berx, G., Foidart, J.-M., Gilles, C., & Winkler, R. (22 February 2013). Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression. Biochemical and Biophysical Research Communications, 431 (4), 652. doi:10.1016/j.bbrc.2013.01.070  Peer reviewed |
 | Nolens, G., Pignon, J.-C., Koopmansch, B., Elmoualij, B., Zorzi, W., De Pauw, E., & Winkler, R. (11 November 2009). Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines. Breast Cancer Research, 11 (6). doi:10.1186/bcr2450 Peer Reviewed verified by ORBi |
 | Pignon, J.-C., Koopmansch, B., Nolens, G., Delacroix, L., Waltregny, D., & Winkler, R. (01 April 2009). Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines. Cancer Research, 69 (7), 2941-2949. doi:10.1158/0008-5472.CAN-08-3760 Peer Reviewed verified by ORBi |
 | Ganeff, C., Chatel, G., Munaut, C., Frankenne, F., Foidart, J.-M., & Winkler, R. (2009). The IGF system in in-vitro human decidualization. Molecular Human Reproduction, 15 (1), 27-38. doi:10.1093/molehr/gan073 Peer Reviewed verified by ORBi |
Nolens, G., Elmoualij, B., Zorzi, W., De Pauw, E., & Winkler, R. (2008). Investigating the role of Ku70/86 proteins as AP-2 cofactors involved in ERBB2 gene overexpression in breast cancer cell lines [Poster presentation]. AACR (American Association for Cancer Research) annual meeting 2008, San Diego, CALIFORNIA, USA, 12-16 April 2008. |
 | Allouche, A., Nolens, G., Tancredi, A., Delacroix, L., Mardaga, J., Fridman, V., Winkler, R., Boniver, J., Delvenne, P., & Begon, D. (January 2008). The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors. Breast Cancer Research, 10 (1), 9. doi:10.1186/bcr1851 Peer Reviewed verified by ORBi |
 | Chatel, G., Ganeff, C., Boussif, N., Delacroix, L., Briquet, A., Nolens, G., & Winkler, R. (15 December 2007). Hedgehog signaling pathway is inactive in colorectal cancer cell lines. International Journal of Cancer, 121 (12), 2622-2627. doi:10.1002/ijc.22998 Peer Reviewed verified by ORBi |
Pignon, J.-C., Delacroix, L., Waltregny, D., & Winkler, R. (2006). Androgens regulation of the ERBB1 and ERBB2 oncogene expression in human prostate cancer cells. Acta Clinica Belgica, 61 (2, MAR-APR), 95-95. Peer Reviewed verified by ORBi |
  | Pignon, J.-C., Delacroix, L., Waltregny, D., & Winkler, R. (2006). Regulation by androgens of EGF receptor family members in prostate cancer cells. Proceedings of the American Association for Cancer Research. Peer reviewed |
 | Delacroix, L., Begon, D., Chatel, G., Jackers, P., & Winkler, R. (September 2005). Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells. DNA and Cell Biology, 24 (9), 582-594. doi:10.1089/dna.2005.24.582 Peer Reviewed verified by ORBi |
 | Begon, D., Delacroix, L., Vernimmen, D., Jackers, P., & Winkler, R. (01 July 2005). Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells. Journal of Biological Chemistry, 280 (26), 24428-34. doi:10.1074/jbc.M503790200 Peer Reviewed verified by ORBi |
 | El Yafi, F., Winkler, R., Delvenne, P., Boussif, N., Belaiche, J., & Louis, E. (March 2005). Altered expression of type I insulin-like growth factor receptor in Crohn's disease. Clinical and Experimental Immunology, 139 (3), 526-533. doi:10.1111/j.1365-2249.2004.02724.x Peer Reviewed verified by ORBi |
 | Vernimmen, D., Guéders, M., Pisvin, S., Delvenne, P., & Winkler, R. (01 September 2003). Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers. British Journal of Cancer, 89 (5), 899-906. doi:10.1038/sj.bjc.6601200 Peer Reviewed verified by ORBi |
 | Vernimmen, D., Begon, D., Salvador, C., Gofflot, S., Grooteclaes, M., & Winkler, R. (15 February 2003). Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression. Biochemical Journal, 370 (Pt 1), 323-329. doi:10.1042/BJ20021238 Peer Reviewed verified by ORBi |
 | Pequeux, C., Breton, C., Hendrick, J.-C., Hagelstein, M.-T., Martens, H., Winkler, R., Geenen, V., & Legros, J.-J. (15 August 2002). Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling. Cancer Research, 62 (16), 4623-4629. Peer Reviewed verified by ORBi |
Delacroix, L., & Winkler, R. (2002). Distal regulatory ERBB2 promoter regions implicated in gene overexpression in breast cancer cells [Poster presentation]. The European Association for Cancer Research Conference, Granada, Spain. |
Delacroix, L., & Winkler, R. (04 May 2001). Role of a distal activating region in ERBB2 overexpression in breast cancer cells [Poster presentation]. Bioforum meeting, Liège, Belgium. |
Delacroix, L., Begon, D., & Winkler, R. (01 December 2000). Role of a distal ERBB2 promoter region in the gene overexpression in breast cancer cells [Poster presentation]. Congrès annuel de la Société Belge de Biochimie, Liège, Belgium. |
Delacroix, L., & Winkler, R. (October 2000). Analysis of a distal HER2 promoter activator in breast tumor cell lines [Poster presentation]. Bioforum meeting, Liège, Belgium. |
Winkler, R., Pasleau, F., Boussif, N., & Hodzic, D. (July 2000). Le systeme IGF: synthese et donnees recentes. Revue Médicale de Liège, 55 (7), 725-39. Peer reviewed |
 | Kecha, O., Brilot, F., Martens, H., Franchimont, N., Renard, C., Greimers, R., Defresne, M.-P., Winkler, R., & Geenen, V. (March 2000). Involvement of Insulin-Like Growth Factors in Early T Cell Development: A Study Using Fetal Thymic Organ Cultures. Endocrinology, 141 (3), 1209-17. doi:10.1210/endo.141.3.7360 Peer Reviewed verified by ORBi |
Delacroix, L., & Winkler, R. (2000). The strong transcriptional activator AP2 binds a distal HER2 enhancer in HER2 overexpressing mammary cancer cell lines [Poster presentation]. Euregional Oncology Meeting, Aachen, Germany. |
Delacroix, L., Begon, D., & Winkler, R. (2000). Role of a distal ERBB2 promoter activating region in overexpression in breast cancer cells [Poster presentation]. The American Association for Cancer Research annual meeting, New Orleans, United States. |
 | Hodzic, D., Frey, B., Delneuville, D., Scarcez, T., Grooteclaes, M., & Winkler, R. (19 August 1999). Cloning of Breakpoints in and Downstream the Igf2 Gene That Are Associated with Overexpression of Igf2 Transcripts in Colorectal Tumours. Oncogene, 18 (33), 4710-7. doi:10.1038/sj.onc.1202877 Peer Reviewed verified by ORBi |
 | Kecha, O., Martens, H., Franchimont, N., Achour, I., Hazee-Hagelstein, M.-T., Charlet-Renard, C., Geenen, V., & Winkler, R. (June 1999). Characterization of the Insulin-Like Growth Factor Axis in the Human Thymus. Journal of Neuroendocrinology, 11 (6), 435-40. doi:10.1046/j.1365-2826.1999.00343.x Peer Reviewed verified by ORBi |
Kecha, O., Brilot, F., Martens, H., Greimers, R., Defresne, M.-P., Winkler, R., Greiner, D. L., & Geenen, V. (1999). Thymic insulin-related polypeptides: role in T cell selection and in central self-tolerance of the insulin family. In The Endocrine Society, Proceedings of the 81st Annual Meeting of the Endocrine Society. Peer reviewed |
 | Winkler, R., Delacroix, L., Bensbaho, K., Lambert, S., Collette, J., & Hodzic, D. (1999). IGF-II in primary human colorectal tumors: peptide level, activated promoters, parental imprinting and gene rearrangement. Hormone and Metabolic Research, 31 (2-3), 148-54. doi:10.1055/s-2007-978713 Peer Reviewed verified by ORBi |
Kecha, O., Winkler, R., Martens, H., Collette, J., Lefebvre, P., Greiner, D. L., & Geenen, V. (1999). Thymic insulin-related polypeptides in diabetes-prone Bio-Breeding rats. Diabetologia, 42 (Suppl. 1), 29. Peer Reviewed verified by ORBi |
Geenen, V., Kecha, O., Achour, I., Goxe, B., Winkler, R., & Lefèbvre, P. (1997). Molecular dissection of the insulin-like growth factor axis in the human thymus. Diabetologia, 40, 23. Peer Reviewed verified by ORBi |
Kecha, O., Achour, I., Martens, H., Winkler, R., Lefebvre, P., & Geenen, V. (1997). Characterization of the insulin-like growth (IGF) axis in the human thymus. In The Endocrine Society, Proceedings of the 77th Annual Meeting of the Endocrine Society (pp. 150 (P3-259). Peer reviewed |
 | Hodzic, D., Delacroix, L., Willemsen, P., Bensbaho, K., Collette, J., Broux, R., Lefebvre, P., Legros, J.-J., Grooteclaes, M., & Winkler, R. (1997). Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma. Hormone and Metabolic Research, 29 (11), 549-55. doi:10.1055/s-2007-979099 Peer Reviewed verified by ORBi |
 | Pasleau, F., Grooteclaes, M., & Winkler, R. (12 May 1990). Using a molecular titration assay to quantitate and characterize the c-erbB2 mRNA synthesized in human mammary adenocarcinoma cell lines. |
Lambert, S. A., Martial, J., & Winkler, R. (1986). Loss of one Ha-rasl allele in some human colorectal tumours. Leukemia Research, 10, 993. Peer Reviewed verified by ORBi |